Net Loss Per Share (Details) - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total (in shares) | 2,359,385 | 289,409 |
| Options and unvested stock units outstanding | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total (in shares) | 129,067 | 252 |
| Warrants outstanding | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total (in shares) | 2,096,933 | 228,369 |
| Convertible promissory notes | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total (in shares) | 133,269 | 60,672 |
| Contingent Sponsor Earnout Shares | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Total (in shares) | 116 | 116 |